Molecular‐Based Magnetic Resonance Multimodal Probes for Tumor Biomarker Imaging
Chemistry – A European Journal · 2026
DOI: 10.1002/chem.71291 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemistry – A European Journal, 2026. Verfasst von Jian Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Magnetic Resonance Spectroscopy and Imaging, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Physics and …. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Biomarkers, Tumor, Neoplasms, Molecular Probes. Die Arbeit nennt 104 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Cancer remains a formidable global health challenge, necessitating advanced strategies to mitigate its profound socio‐economic and clinical impacts. Central to cancer progression is the tumor microenvironment (TME), a complex landscape characterized by unique physiological and molecular alterations. These TME biomarkers that can interact with chemical probes offer critical molecular targets for early detection and longitudinal therapeutic monitoring. While magnetic resonance imaging (MRI) is indispensable for clinical diagnostics due to its superior soft‐tissue contrast, its utility is frequently limited by inherently low sensitivity. To overcome these limitations, recent advances have focused on multimodal imaging strategies and TME‐responsive probes. By integrating MRI with complementary imaging modalities, these probes enable the consolidation of multidimensional data—bridging the gap between microscopic molecular recognition and macroscopic in vivo imaging. Although small‐molecule‐based multimodal probes are currently less common than nanoparticle‐based counterparts, they offer distinct advantages in pharmacokinetics and targeting precision. This review systematically summarizes recent design strategies and the transformative potential of small‐molecule responsive probes. We conclude by discussing the future outlook for MR‐based multimodal agents as essential tools for advancing personalized precision oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Magnetic Resonance Spectroscopy and Imaging, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Physics and Mathematics, Innovation Academy for Precision Measurement Science and…
- University of Chinese Academy of Sciences, Beijing, P. R. China.
- School of Biomedical Engineering, Hainan University, Sanya, P. R. China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, J., Jiang, M., Xiao, L., Li, S., Liu, Y., Liu, Z., Zhang, L., & Chen, S. (2026). Molecular‐Based Magnetic Resonance Multimodal Probes for Tumor Biomarker Imaging. Chemistry – A European Journal. https://doi.org/10.1002/chem.71291
Vancouver
Zhang J, Jiang M, Xiao L, Li S, Liu Y, Liu Z, et al. Molecular‐Based Magnetic Resonance Multimodal Probes for Tumor Biomarker Imaging. Chemistry – A European Journal. 2026. doi:10.1002/chem.71291
BibTeX
@article{Zhang2026,
author = {Zhang, Jian and Jiang, Mou and Xiao, Long and Li, Sha and Liu, Yudun and Liu, Zhaoqing and Zhang, Lei and Chen, Shizhen},
title = {Molecular‐Based Magnetic Resonance Multimodal Probes for Tumor Biomarker Imaging},
journal = {Chemistry – A European Journal},
year = {2026},
doi = {10.1002/chem.71291}
}
EUVIMED